Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a Toll-like receptor 9 (TLR9) agonist that is a CpG-C type oligonucleotide, and the use of the combination therapies for the treatment of cancer.

Abstract: Robotic systems and methods for collecting trash are provided. The robotic system includes a vehicle, a camera, a trash collection unit, an actuator, and a controller. The vehicle includes a drive. The camera moves with the vehicle to capture images of the trash while the vehicle moves along ground. The trash collection unit is carried by the vehicle to collect the trash. The trash collection unit includes a vacuum pump and a collection conduit. The actuator is operatively coupled to the collection conduit to adjust a position of the collection conduit relative to the vehicle to position the collection conduit adjacent to the trash to collect the trash. The controller is coupled to the drive, the camera, the trash collection unit, and the actuator to coordinate movement of the vehicle, positioning of the collection conduit, and operation of the vacuum pump to collect the trash.

Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a Toll-like receptor 9 (T1119) agonist that is a CpG-C type oligonucleotide, and the use of the combination therapies for the treatment of cancer.

Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a Toll-like receptor 9 (TLR9) agonist that is a CpG-C type oligonucleotide, and the use of the combination therapies for the treatment of cancer.

Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a Toll-like receptor 9 (TLR9) agonist that is a CpG-C type oligonucleotide, and the use of the combination therapies for the treatment of cancer.

Abstract: The present disclosure describes combination therapies comprising an anti-IL-10 antibody or antigen-binding fragment thereof and a CpG-C type oligonucleotide, and the use of the combination therapies for the treatment of cancer.

Abstract: The present invention relates to a binding compound which binds to human APRIL. More specifically the invention provides, compositions of anti-APRIL specific antibodies and methods to use such antibodies in modulating the biological activity APRIL, particularly in inflammatory diseases, inhibition of cell proliferation and cancer.

Abstract: The present invention relates to a binding compound which binds to human APRIL. More specifically the invention provides, compositions of anti-APRIL specific antibodies and methods to use such antibodies in modulating the biological activity APRIL, particularly in inflammatory diseases, inhibition of cell proliferation and cancer.

Abstract: The present invention relates to a binding compound which binds to human APRIL. More specifically the invention provides, compositions of anti-APRIL specific antibodies and methods to use such antibodies in modulating the biological activity APRIL, particularly in inflammatory diseases, inhibition of cell proliferation and cancer.

Abstract: The present invention relates to a binding compound which binds to human APRIL. More specifically the invention provides, compositions of anti-APRIL specific antibodies and methods to use such antibodies in modulating the biological activity APRIL, particularly in inflammatory diseases, inhibition of cell proliferation and cancer.

Abstract: The present invention relates to a binding compound which binds to human APRIL. More specifically the invention provides, compositions of anti-APRIL specific antibodies and methods to use such antibodies in modulating the biological activity APRIL, particularly in inflammatory diseases, inhibition of cell proliferation and cancer.

Abstract: The present invention relates to a binding compound which binds to human APRIL. More specifically the invention provides, compositions of anti-APRIL specific antibodies and methods to use such antibodies in modulating the biological activity APRIL, particularly in inflammatory diseases, inhibition of cell proliferation and cancer.

Abstract: A system board is to be designed as a standardized system board so that it can be used either in a mobile computer system or in a non-mobile computer system. In some embodiments, the system board may be fundamentally designed for the mobile computer system. Some reconfiguration may be performed to use the system board in the non-mobile computer system.

Abstract: A computer system is disclosed herein. The computer system includes a base, a plurality of keys supported by the base, at least one arm having first and second ends, the first end being pivotally secured to the base, and a screen secured to the second end of the arm. In one embodiment, the arm is extensible. In one embodiment, the screen is pivotal relative to the arm. In one embodiment, the arm is extensible and the screen is pivotal relative to the arm.

Abstract: According to some embodiments, systems and apparatus for enhanced mobile computing platforms are provided. For example, an apparatus or system may comprise a universal computational package, comprising a processor, a memory coupled to the processor, a plurality of instructions stored in the memory directed to at least one specific use of the universal computational package, and a plurality of interface controllers coupled to the processor, wherein each of the plurality of interface controllers is operable to cause the processor to execute the plurality of stored instructions in accordance with the presence of a use-specific user interface cover associated with the at least one specific use of the universal computational package.

Abstract: A docking solution for a tablet notebook computer is described. Specifically, the docking solution provides a way to adjust the tilt angle of the tablet screen while conserving area. Further, a main connector and an auxiliary connector is provided to provide an electrical contact between the base unit and the tablet screen when the tablet notebook computer is in a convertible mode.

Abstract: A computer system includes a support arm that when unfolded may enable a display section to be operated in a laptop mode, tablet mode, or convertible mode. A latching mechanism engages or disengages the support arm to or from the display section.

Abstract: A computer system includes a panel that when unfolded may expose a keyboard and a stand. The stand is to support the computer system in its upright position. The keyboard may be a wireless keyboard and may be part of a keyboard tray. When the panel is unfolded, the keyboard may be slid into or out of the stand. When the keyboard is slid into the stand, the keyboard tray and the stand form the panel. When the panel is folded, a carrying handle may be used to carry the computer system from one place to another place.

Abstract: A computer system includes a panel that when unfolded may expose a keyboard and a stand. The stand is to support the computer system in its upright position. The keyboard may be a wireless keyboard and may be part of a keyboard tray. When the panel is unfolded, the keyboard may be slid into or out of the stand. When the keyboard is slid into the stand, the keyboard tray and the stand form the panel. When the panel is folded, a carrying handle may be used to carry the computer system from one place to another place.

Abstract: In some embodiments, a controller detects a board coupling condition and performs a shutdown in response to the board coupling condition. Other embodiments are described and claimed.